CODX (NASDAQ:CODX) is making a strategic push to scale its global diagnostics platform, announcing a major expansion of ...

Joe Reader is running the London Marathon to raise awareness for Coeliac UK and help fund crucial research which could lead to more diagnoses.

The boss of Yorkshire-based lateral flow test developer Abingdon Health has said the company is still benefiting after the pandemic turned a once rarely discussed product into a household name.

Researchers are seeking pregnant patients for the clinical trial of a drug designed to decrease the risk of fetal anemia in patients with hemolytic disease of the fetus and newborn (HDFN).

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...

Two of the three foreign laboratories authorised by the Magistrate Court sitting in the Ikorodu area of Lagos State have declined to conduct the paternity ...

Discover how Ovine Johne’s Disease affects UK flocks, its hidden spread, key signs, and the biosecurity steps that help protect sheep health.

Background Adalimumab is an effective first-line biologic therapy used to treat children and young people (CYP) with juvenile idiopathic arthritis (JIA) and non-infectious uveitis (NIU). However, the ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...